Rimonabant Appetite Suppressant Review
Product is known to treat obesity as well as helping people with conditions such as heart diseases and diabetes mellitus type II, it can help in the cessation of smoking
There are serious side effects brought about by Rimonabant. It can actually cause severe depression and suicidal tendencies.
Rimonabant is not approved by the Food and Drug Administration. Although it can help in weight loss and smoking cessation, there are serious side effects that can happen when this drug is being taken. A consumer should be wise enough to weigh the pros and cons of a product prior to giving it a try.
What is Rimonabant?
Acomplia is an appetite suppressant that is also used to help in stopping smoking. This product is manufactured by a French pharmaceutical company called Sanofi-Aventis. The generic name for Acomplia is Rimonabant. This is actually a cannabinoid (CB1) receptor antagonist. Being a receptor antagonist, it blocks the CB1 receptors located in the brain and as well as those in the peripheral organs. This action is believed to suppress the appetite and also decreases dependence on tobacco. Sad to say, Rimonabant is not approved by the Food and Drug Administration to be used as a smoking cessation product and as an appetite suppressant. Despite this, Rimonabant is widely available online as well as in European countries but used only as an appetite suppressant. Last October 2008, this product was suspended in Europe as advised by the European Medicines Agency.
Ingredients present in Rimonabant
croscarmellose sodium (E468)
magnesium stearate
microcrystalline cellulose (E460)
sodium laurilsulfate (E487)
Features of Rimonabant
Out of three users of Rimonabant, one reported to have reduced 10% of the total body fat. In addition, those users have also prevented the lost pounds from returning over the next two years as long as they maintained Rimonabant use. Rimonabant should be used by people with a body mass index of 30 or higher as this is already considered obesity. When Rimonabant is used with exercise and a balanced diet, positive results can be expected; however, keep in mind that Rimonabant is not recommended for people who would just like to lose some pounds. Sanofi-Aventis, the company that manufactures Rimonabant, researched on the product’s effects on smoking cessation and came up with positive results. Rimonabant can also decrease incidence of addiction to opiate, ethanol, and cocaine.
Benefits of Rimonabant
Product is known to treat obesity as well as helping people with conditions such as heart diseases and diabetes mellitus type II
It can help in the cessation of smoking
Drawbacks of Rimonabant
There are serious side effects brought about by Rimonabant. It can actually cause severe depression and suicidal tendencies. Development of degenerative diseases of the brain such as Parkinson’s disease, Amyotrophic lateral sclerosis, Huntington’s disease, and Multiple sclerosis are also likely to happen.
Rimonabant has been prohibited in the European market.
Rimonabant is not approved by the U.S. Food and Drug Administration.
The product is hard to find and purchase
Conclusion on Rimonabant
Rimonabant is not approved by the Food and Drug Administration. Although it can help in weight loss and smoking cessation, there are serious side effects that can happen when this drug is being taken. A consumer should be wise enough to weigh the pros and cons of a product prior to giving it a try.
